Insider Stock Trading History of Kelly Thomas Patrick


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kelly Thomas Patrick since year 2005. The trader's CIK number is 1410514. At the time of this reporting, Kelly Thomas Patrick is the Chief Financial Officer of Deciphera Pharmaceuticals, Inc. . (stock ticker symbol DCPH). See this page for all insider trading activities at Deciphera Pharmaceuticals, Inc. .

Note that in the past Kelly Thomas Patrick also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Kelly Thomas Patrick since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-02-19 DCPH Deciphera Pharmaceuticals, Inc. Sale 1,500 30.00 45,000
2019-02-19 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 1,500 1.89 2,835
2019-01-07 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 5,000 1.89 9,450
2019-01-07 DCPH Deciphera Pharmaceuticals, Inc. Sale 5,000 25.18 125,900
2007-08-22 CRTX Critical Therapeutics Inc Buy 4,000 2.08 8,316

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kelly Thomas Patrick (Chief Financial Officer of Deciphera Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.